S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Homology Medicines (FIXX) Insider Trading & Ownership

Homology Medicines (NASDAQ:FIXX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$13,375.58
Get FIXX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Homology Medicines stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FIXX Insider Buying and Selling by Quarter

Homology Medicines Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/9/2024Arthur TzianabosDirectorSell26,074$0.29$7,431.09  
1/3/2024Paul AllowayInsiderSell14,560$0.29$4,149.60  
9/6/2023Albert SeymourInsiderSell2,896$0.58$1,665.20  
8/2/2023Julie JordanInsiderSell198$0.66$129.69  
(Data available from 1/1/2013 forward)

FIXX Insider Trading Activity - Frequently Asked Questions

Who is on Homology Medicines's Insider Roster?

The list of insiders at Homology Medicines includes Albert Seymour, Arthur Tzianabos, Julie Jordan, Michael Lee Blum, Paul Alloway, Timothy P Kelly, and W Bradford Smith. Learn more on insiders at FIXX.

What percentage of Homology Medicines stock is owned by insiders?

16.10% of Homology Medicines stock is owned by insiders. Learn more on FIXX's insider holdings.

Which Homology Medicines insiders have been selling company stock?

The following insiders have sold FIXX shares in the last 24 months: Albert Seymour ($1,665.20), Arthur Tzianabos ($22,187.33), Julie Jordan ($129.69), Michael Lee Blum ($3,411.06), and Paul Alloway ($20,048.85).

How much insider selling is happening at Homology Medicines?

Insiders have sold a total of 91,798 Homology Medicines shares in the last 24 months for a total of $47,442.13 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:FIXX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners